The Katfriends at Newton Media wish to inform that the well-reputed and -attended Life Sciences Patent Network (LSPN) North America Fall 2024 conference is returning to San Francisco (CA, USA) on 15 and 16 October 2024.
As in the previous editions, expert speakers will dive deep into the most pressing challenges and opportunities shaping the future of life sciences. This year's speaker line up includes representatives from Johnson & Johnson, Pfizer, Bristol Myers Squibb, Illumina, 10x Genomics, BioMarin and many more. With over 60+ key industry speakers, and 150+ delegates, the conference organizers always ensure that at least 50% of the audience is in-house, offering the best opportunity to connect with peers.
This year’s agenda features the following topics:
- Aligning innovation, regulation and IP protection
- International harmonization and global patent and enforcement strategies
- Lessons from the frontline of the UPC
- Navigating enablement and written description requirements in the USPTO
- AI and machine learning in drug discovery: patenting AI-generated inventions
- The evolving role of IP lawyers within life sciences
The organizers have also kindly offered a 15% discount to IPKat readers. To learn more about the conference, register, and claim your discount, just click here and use promo code KAT15.
Life Sciences Patent Network (LSPN) returns to San Francisco with 15% discount for IPKat readers
Reviewed by Eleonora Rosati
on
Tuesday, August 13, 2024
Rating:
Reviewed by Eleonora Rosati
on
Tuesday, August 13, 2024
Rating:
Follow the IPKat on LinkedIn 
![[Guest post] EUIPO Second Board of Appeal refers case to Grand Board of Appeal following earlier refusal to register a photograph of a man’s head/face as an EU trade mark](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUj9v-k3DYaSVMR4lsmKDLHVB5nIoINuvZNbH2TQCelrfaAE9qmGSAQs-plzQ7HnZ7Svk_gRdrIODp0Nat5vpWajduit3xkArNhK76AHhX770RIJ62thfCVI5fnvcXU-5zH4NkUSfPY9FjRMFiK7OKJ7m7YSo2FzhyPSoA8ZWCsxaOXb0bBCoPQA/s72-c/Picture%201.png)
![[Guest post] Benelux Office rules on opposition proceedings prepared by ChatGPT](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi29VY0rNNP1Hqyz8RgB47r4q7fhqQfYHxsEbX_RKmT4KU5Y_vg7vB6dsAW91CidjMfJ38klTvD4mMtZb3QmwFPAHaGF88BPttWSbfYvo7UUg7MpFRTNtEjThmG0QaX2qZFFHSnN71i3YQZSBFC0SL7PgkAlme-XH8cSNWRFbOAOuLr_LMOGcImLQ/s72-c/Screenshot%202024-12-04%20at%2020.45.58.png)
Posts
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html